Patrick Kleyn joined Rhythm in 2018 with over 25 years’ experience in human genetics and genomics, and he was named as head of TRAD in 2021. Prior to joining Rhythm, Patrick has held leadership roles in academia, biotech and large pharmaceutical companies, as his work has focused on the application of genomic technologies for drug and biomarker discovery and development. He began his career at Millennium Pharmaceuticals initially working on obesity target discovery and ultimately leading the genomics organization. He subsequently served as Chief Scientific Officer at Gemini Genomics and as Head of Scientific Planning at the Broad Institute during its inception and launch. He left the Broad to co-found Ligon Discovery and subsequently joined EMD Serono as the Head of External Innovation at its Boston site. Patrick earned his bachelor’s of Natural Sciences at Cambridge University, his Ph.D. in human genetics at University College London and carried out postdoctoral research in neuromuscular diseases at Columbia University.